Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.
Press releases published on June 4, 2025
Nordic American Tankers Ltd (NYSE: NAT) – The Hansson family continues to buy more NAT shares
GlobeNewswire
·
June 4, 2025
Wednesday, June 4, 2025 Dear Shareholders and Investors, Founder, Chairman …
Does BTC cloud mining really exist? How can you use it to earn passive income?
GlobeNewswire
·
June 4, 2025
Washington, D.C., USA, June 04, 2025 (GLOBE NEWSWIRE) -- With the increase of Bitcoin ETFs and investor sentiment running high, many news outlets are now publishing and discussing this question: “Is BTC cloud mining real? Can you really make $10,000 a day …
Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma
GlobeNewswire
·
June 4, 2025
Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma Paris, France, June 4th, 2025. Oncovita, a biotechnology company developing innovative virus-based immunotherapies for …
AnorTech Announces Positive Results From Sustainable Cement R&D Program
GlobeNewswire
·
June 4, 2025
VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- Vancouver, BC – ANORTECH INC. (“AnorTech” or the “Company”) (TSX Venture Exchange “ANOR”; OTC “ANORF”) is pleased to announce the successful completion of the latest phase of its research and …
Game, Set, Match: JOE & THE JUICE Welcomes Novak Djokovic to the Family
GlobeNewswire
·
June 4, 2025
COPENHAGEN, Denmark, June 04, 2025 (GLOBE NEWSWIRE) -- Today, JOE …
Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes
GlobeNewswire
·
June 4, 2025
June 4, 2025 Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of …
Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development
GlobeNewswire
·
June 4, 2025
PITTSBURGH, June 04, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced that it …
Brera Holdings PLC (Nasdaq: BREA) and Castellammare Salute Juve Stabia’s Stellar Season and Semifinal Run in the Serie A Promotion Playoff;
GlobeNewswire
·
June 4, 2025
Mayor Announces €5,000,000 (US$5,850,000) in subsidies from the Campagna Region for the refurbishment of Romeo Menti Stadium Le Vespe finished 5th in Italy’s Serie B Regular Season and Finish within one match of advancing to Serie A Juve Stabia …
Results of Venetus’ proposed placing of shares in Theon International to strengthen the free float and liquidity of the stock
GlobeNewswire
·
June 4, 2025
PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 4 June 2025 - Theon International Plc (“Theon” or the “Company”) has been informed that its shareholder Venetus Limited (“Venetus”) (whose shares are primarily held by key executives of Theon Group …
Foster child turned inspirational speaker's teacher tribute film wins Cannes
GlobeNewswire
·
June 4, 2025
MILTON KEYNES, United Kingdom, June 04, 2025 (GLOBE NEWSWIRE) -- Re-Story Your Life, a short documentary based on the lived experience of multi-award-winning international speaker Jaz Ampaw-Farr, founder of Be Human First Ltd, has received the Programmer’s …
Allarity Therapeutics Announces Research Collaboration with Indiana Biosciences Research Institute to Further Advance Understanding of Stenoparib’s Unique, Dual Therapeutic Mechanism of Action
GlobeNewswire
·
June 4, 2025
TARPON SPRINGS, Fla., June 4, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as …
Integral Metals Engages Geological Consultant for KAP Project Desktop Study and Resource Planning
GlobeNewswire
·
June 4, 2025
CALGARY, Alberta, June 04, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce that it has engaged Understood Mineral Resources Ltd. (“UMR”), a geological and …
Fusion Fuel Green PLC Announces Forthcoming Annual General Meeting
GlobeNewswire
·
June 4, 2025
DUBLIN, June 04, 2025 (GLOBE NEWSWIRE) -- via IBN – Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”) today announced that it will hold its Annual General Meeting (“AGM”) on June 25, 2025, at 2:00 PM (Dublin time) at the offices of …
Pride Month: myGwork’s Free WorkPride 2025 Conference Empowers Allies to Step Up
GlobeNewswire
·
June 4, 2025
LONDON, June 04, 2025 (GLOBE NEWSWIRE) -- Tightening DEI regulations in the US and recent rulings – such as the UK Supreme Court’s narrowing of the legal definition of “sex” – are creating growing uncertainty in workplaces worldwide. These developments not …
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796
GlobeNewswire
·
June 4, 2025
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796 Pioneering small-molecule program, NT-0796, targets chronic inflammation and its fundamental role in the complex cycle of …
Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11, 2025 at 10:40 a.m. ET. The …
Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
GlobeNewswire
·
June 4, 2025
Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2 All three cohorts show separation from placebo with statistically significant difference from placebo at day 28 Cohort 3 demonstrates clinically meaningful reduction in itch as …
UPDATE: RIB Software Launches Global Customer Campaign: “You See It. Together, We’ll See It Through”
GlobeNewswire
·
June 4, 2025
Stuttgart, Germany, June 04, 2025 (GLOBE NEWSWIRE) -- Stuttgart, Germany – May 2025 – RIB Software, a global leader in engineering and construction software technology, today announced the launch of its latest global brand campaign: “You See It. Together, …
IQ121 Launches Advanced Legacy Building App, Digitally Safeguarding Vital Documents and Preserving Cherished Memories
GlobeNewswire
·
June 4, 2025
LONDON, June 04, 2025 (GLOBE NEWSWIRE) -- A loved one's passing brings both emotional pain and the heavy weight of complex legal and administrative tasks, leaving families with more to manage than just grief during their time of loss. Today, IQ121 …
IQ121 Launches Advanced Legacy Building App, Digitally Safeguarding Vital Documents and Preserving Cherished Memories
GlobeNewswire
·
June 4, 2025
LONDON, June 04, 2025 (GLOBE NEWSWIRE) -- A loved one's passing brings both emotional pain and the heavy weight of complex legal and administrative tasks, leaving families with more to manage than just grief during their time of loss. Today, IQ121 …